Feature|Videos|July 21, 2025
Video Interview With Chris Hagen, President of SCIEX
Author(s)SCIEX, Chris Hagen
Chris Hagen, President of SCIEX, shares his vision for the company and introduces the new ZenoTOF 8600 system, featuring electron activated dissociation (EAD) that provides more complete molecule identification and characterization and ZTScan for enhanced Q1 window selectivity.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
2
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
3
How Mitigation and Maintenance Protect Against Future Risk
4
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
5
